<DOC>
	<DOCNO>NCT02182492</DOCNO>
	<brief_summary>Endoscopic sinus surgery ( ESS ) widely consider gold standard surgical management chronic rhinosinusitis ( CRS ) fail maximal medical therapy . Nevertheless , postoperation medical therapy consider crucial procedure success ESS . Both glucocorticoid macrolide antibiotic recommend treatment CRS , effect postoperation medical therapy ESS need clinical data clarify . The purpose prospective , randomize , study determine effect glucocorticoid macrolide antibiotic postoperation medical therapy ESS different subtypes CRS .</brief_summary>
	<brief_title>Efficacy Macrolide Glucocorticoid Treatment Chronic Rhinosinusitis Patients After Endoscopic Sinus Surgery ( ESS )</brief_title>
	<detailed_description />
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>Meeting CRS diagnostic criterion include CRSsNP CRSwNP base EP3OS definition Age ≥16 ≤70 year Chinese either sex Failure conventional medical therapy accord EP3OS recommendation Pregnant breastfeed woman Cystic fibrosis Congenital ciliary dyskinesia Sinonasal fungal disease Systemic vasculitis Granulomatous disease Tumor Immunodeficiency Allergic clarithromycin topical corticosteroid With upper respiratory tract infection within 4 week enter study With serious metabolic , cardiovascular , autoimmune , neurology , blood , digestive , cerebrovascular , respiratory system disease , disease interfere evaluation result affect subject ' safety glaucoma tuberculosis With emotional mental problem Have receive immunotherapy within previous 3 month Have history local systemic medication , glucocorticoid macrolides within 4 week Have acute asthmatic within 4 week enter study</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>